Sign In
Free Newsletter
Wyndham urges shareholders to reject Choice’s takeover bid
The Parsippany-based budget hotel operator said it determined the move is not in the best interest of the company and that the rival chain “failed to address the major value gap and risks of their offer.”
Cognizant to acquire Colorado workflow-solutions firm
The move to buy ServiceNow partner Thirdera is significant because it “furthers the efforts of Cognizant and ServiceNow’s strategic partnership ... to build a $1 billion combined business focused on AI-driven automation," the Teaneck-based firm told NJBIZ.
Parsippany-based Wyndham faces hostile takeover bid from Choice Hotels
The offer puts the value of the deal at about $8 billion and follows several buyout attempts from the rival hotel chain that were previously declined.
J&J MedTech buys cardiac device company for $400M
"The team at Laminar is driven by our vision to develop and deliver an innovative solution to help patients live without the fear of stroke, or the need for long-term use of blood thinners,” Lamar President and CEO Randy Lashinski said about the company's technology.
Tabula Rasa to go private after $570M acquisition
Stockholders have approved the deal, whereby the medical technology company would combine with ExactCare Pharmacy, a portfolio company of the buyer, Nautic Partners.
Campbell’s $2.7B Rao’s acquisition pushed to mid-2024
The delay comes as the FTC seeks more information about the proposed deal, which was originally expected to close by December of this year.
Citius Pharma’s $675M merger deal advances (updated)
In 2022, the Cranford-based company announced its intentions to spin off its subsidiary to focus on a developing treatment for cutaneous T-cell lymphoma.
Choice Hotels offers nearly $8B to buy Wyndham Hotels & Resorts
The bid follows a breakdown in merger talks between the budget lodging providers that the potential acquiror says would benefit franchisees as well as business and leisure travelers.
Bristol Myers Squibb to acquire San Diego firm for up to $5.8B
Mirati is a commercial-stage targeted oncology company whose mission is to develop therapies for the treatment of cancer.
Bausch + Lomb closes $2.5B XIIDRA acquisition
“We expect to quickly take a leading position in the growing prescription dry eye category with the XIIDRA acquisition and MIEBO launch and, importantly, help the millions of patients not currently receiving adequate treatment for dry eye disease,” Bausch + Lomb Chairman and CEO Brent Saunders said.
Spector & Ehrenworth PC merges with Scarinci Hollenbeck
Founded in 1993 by stepbrothers Brian Spector and Douglas Ehrenworth, the Florham Park-based firm specializes in commercial litigation, bankruptcy and creditors’ rights, commercial transactions, real estate and business organizations.
Inspira completes Salem Medical Center integration
Officials say the rebranded Inspira Medical Center Mannington facility represents a "seamless expansion" of Inspira Health's more than 70-year legacy of providing safe, high-quality care to Salem County residents.
